Aussie researchers to start cancer drug trial to treat COVID-19 – SHINE

A type of Australian cancer drug is set to begin human trials for the treatment of COVID-19, with the hopes of stopping the virus in its tracks before it leaves the nose and throat.
The drug, called BromAc, is administered directly as a nasal spray and could potentially stop the virus from spreading to other areas including the lungs, where it can cause deadly complications.
Lead developer, Professor David Morris told Xinhua on Monday that the drug works by dissolving spike proteins on the sur…

Click here to view the original article.